When Patient Diversity Informs Formulation: Reimagining Treatment for Seborrheic Dermatitis Meredith Tyree PolaskeyHeather Woolery-LlloydRaj Chovatiya Commentary Open access 27 April 2024
Safety and Effectiveness of Percutaneous Ultrasound-Guided Galvanic Current in Tunnels of Patients with Hidradenitis Suppurativa: A Pilot Study Alberto Soto-MorenoCarlos Cuenca-BarralesAlejandro Molina-Leyva Original Research Open access 27 April 2024
Impact of Biologic Therapy on Key Cardiovascular Risk Parameters in a Psoriatic Cohort—a Retrospective Review Joseph JosephKelvin TruongAnnika Smith Brief Report Open access 25 April 2024
Economic Burden of Itch-Related Sleep Loss in Moderate-to-Severe Atopic Dermatitis in the United Kingdom Evangeline J. PierceRussel T. BurgeYunni Yi Original Research Open access 23 April 2024
Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60 Alexander EgebergJason E. HawkesApril Armstrong Original Research Open access 22 April 2024 Pages: 1007 - 1018
Baseline Characteristics and mNAPSI Change from Baseline Scores Through Month 12 for Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with Biologics from PSoHO Elisabeth RiedlAndreas PinterChristopher Schuster Brief Report Open access 22 April 2024
The Epidemiology of Hospital-Treated Alopecia Areata in Denmark, 1995–2016 Sissel Brandt Toft SørensenPrethibha GeorgeVera Ehrenstein Original Research Open access 16 April 2024 Pages: 993 - 1006
Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis Tiago TorresAnne Sohrt PetersenJosé Manuel Carrascosa Original Research Open access 13 April 2024 Pages: 983 - 992
Novel Topical Treatments for Itch Rami H. MahmoudOmar MahmoudGil Yosipovitch Review Open access 13 April 2024 Pages: 829 - 840
Current Diagnostic and Therapeutic Practices in Alopecia Areata in Two Mediterranean Countries: A Survey-Based Study Michela StaraceFrancesca PampaloniZoe Apalla Original Research Open access 10 April 2024 Pages: 953 - 970
Letter to the Editor Regarding: Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study Ruiyao HuYue WangChen Li Letter Open access 09 April 2024 Pages: 1063 - 1065
Psoriasis and Molecular Target Therapies: Evidence of Efficacy in Preventing Cardiovascular Comorbidities Luca PotestioNello TommasinoMatteo Megna Review Open access 09 April 2024 Pages: 841 - 852
Publisher Correction to: Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry Eric L. SimpsonBen LockshinAndrew Korotzer Publisher Correction Open access 09 April 2024
Response to: Letter to Editor Regarding “Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study” A. David Burden Letter Open access 05 April 2024 Pages: 1067 - 1069
Clinical Characteristics and Therapeutic Aspects of Blaschko Linear Psoriasis Ling ChenYufan ChengZhu Shen Brief Report Open access 05 April 2024 Pages: 1039 - 1048
Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis Tina BhutaniJohn KooJ. Gabriel Vasquez Brief Report Open access 04 April 2024 Pages: 1019 - 1025
Acute Systemic Toxicity Caused by Topical Application of EMLA Cream on a Leg Ulcer: Case Report and Review of Literature Sarah Marie HoffmannAnna Luisa HartmannChristoph Mathis Schempp Case Report Open access 03 April 2024 Pages: 1057 - 1062
Utilising SNP Association Analysis as a Prospective Approach for Personalising Androgenetic Alopecia Treatment Manuel Pacareu FrancèsLaura Vila-VecillaGustavo Torres de Souza Original Research Open access 31 March 2024 Pages: 971 - 981
Maintenance of Investigator’s Static Global Assessment Response with Once-Daily Crisaborole in Participants with Mild to Moderate Atopic Dermatitis Lawrence F. EichenfieldLinda F. Stein GoldJuliana M. Canosa Original Research Open access 28 March 2024 Pages: 875 - 892
Effectiveness of Ixekizumab in Chinese Patients with Moderate-Severe Plaque Psoriasis with Special Area Involvement: Subanalysis of a Prospective, Multicenter, Observational Real-World Study Ying LiChengzhi LvYuling Shi Original Research Open access 27 March 2024 Pages: 907 - 918
Virtual Learning Decreases the Carbon Footprint of Medical Education Divya SharmaJulianne RizzoJenny E. Murase Original Research Open access 26 March 2024 Pages: 853 - 859
Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-World Studies April ArmstrongAlvaro González-CanteroAndrew Blauvelt Original Research Open access 23 March 2024 Pages: 933 - 952
Inconsistent Associations Between Risk Factor Profiles and Adjuvant Radiation Therapy (ART) Treatment in Patients with Cutaneous Squamous Cell Carcinoma and Utility of the 40-Gene Expression Profile to Refine ART Guidance Brent R. MoodyAaron S. FarbergWalton A. Taylor Original Research Open access 23 March 2024 Pages: 861 - 873
Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries Sergio Vañó-GalvánAlexander EgebergAnthony Bewley Brief Report Open access 21 March 2024 Pages: 1027 - 1037
Effect of Makeup Use on Depressive Symptoms: An Open, Randomized and Controlled Trial Marcos C. VeçosoSouvenir ZallaVânia R. Leite-Silva Original Research Open access 21 March 2024 Pages: 777 - 791
Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus Luigi GargiuloLuciano IbbaAlessandra Narcisi Original Research Open access 21 March 2024 Pages: 919 - 932
Response Types and Factors Associated with Response Types to Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis from Two Randomized Clinical Trials Alexander EgebergCurdin ConradDiamant Thaçi Original Research Open access 15 March 2024 Pages: 745 - 758
Development and Psychometric Validation of a Patient-Reported Outcome Measure to Assess the Signs and Symptoms of Chronic Hand Eczema: The Hand Eczema Symptom Diary (HESD) Sonja MolinLotte Seiding LarsenMarie L. A. Schuttelaar Original Research Open access 15 March 2024 Pages: 643 - 669
Interleukin-17A Inhibitors in Patients with Psoriasis and Tuberculosis Infection: A 2-Year Prospective Study on Safety Without Preventive Treatment Chun-Xia HeChao WuHong-Zhong Jin Original Research Open access 14 March 2024 Pages: 893 - 906
Atypical Fibroxanthoma Treated with a Topical Combination of Imiquimod, Tazarotene, and 5-Fluorouracil William J. NahmEvangelos V. BadiavasJohn Shen Case Report Open access 12 March 2024 Pages: 1049 - 1056
Satisfaction with Control of Mild to Moderate Atopic Dermatitis with Ruxolitinib Cream: US Physician and Patient Perspectives Lawrence F. EichenfieldJinan LiuPeter Anderson Original Research Open access 08 March 2024 Pages: 685 - 696
Regulation of the Immune Cell Repertoire in Psoriasis Patients Upon Blockade of IL-17A or TNFα Julia TittesJennifer BrellJohannes Stöckl Original Research Open access 08 March 2024 Pages: 613 - 626
Burden of Topical Treatments in Psoriasis and Preferred Criteria of Choice: A Survey-Based Evaluation of Patients in Europe Anthony BewleyLauren HiribarneSicily Mburu Original Research Open access 08 March 2024
A Prospective, Monocentric Case-Control Study on Uncontrolled Psoriasis as Independent Risk Factor for a Hypercoagulable State Tom M. HillaryTine VanhoutvinSéverine Vermeire Original Research Open access 07 March 2024 Pages: 767 - 775
The Need of Differential Diagnosis Between Vulvar Lichen Sclerosus and Autoimmune Dermatoses in Adolescent Girls Agnieszka DulskaJakub BodzionyAgnieszka Drosdzol-Cop Original Research Open access 07 March 2024 Pages: 759 - 766
Safety of Secukinumab from 1 Million Patient-Years of Exposure: Experience from Post-Marketing Setting and Clinical Trials Rui SunMercedes BustamanteVictor Dong Original Research Open access 07 March 2024 Pages: 729 - 743
The Role of the Gut-Joint Axis in the Care of Psoriatic Arthritis: A Two-Sample Bidirectional Mendelian Randomization Study Yihong GanJingqun LiuYongsheng Fan Original Research Open access 07 March 2024 Pages: 713 - 728
The Real-World Effectiveness and Tolerability of a Soothing Cream Containing the Postbiotic Aquaphilus dolomiae Extract-G2 for Skin Healing Yuling ShiEdward LainAline Stennevin Original Research Open access 07 March 2024 Pages: 697 - 712
Response to “Letter to the Editor Regarding ‘Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab vs. Dupilumab in Moderate to Severe Atopic Dermatitis’” Kim RandJuan Manuel Ramos-GoñiJosé-Carlos Armario-Hita Letter Open access 05 March 2024 Pages: 823 - 827
Successful Treatment of Disseminated Granuloma Annulare with Upadacitinib Axel De GreefGhita BenjellounMarie Baeck Case Report Open access 05 March 2024 Pages: 813 - 817
Treatment Patterns and Negative Health Outcomes in Palmoplantar Pustulosis Patients in Germany and the US Alvan ChengXinqing DengBoni E. Elewski Original Research Open access 05 March 2024 Pages: 627 - 641
Botulinum Toxin A and B for Palmoplantar Hyperhidrosis Trond EilertsenBjørn Øivind KvammenØystein Grimstad Brief Report Open access 01 March 2024 Pages: 805 - 811
Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients Ashley WysongAlly‐Khan SomaniSarah T. Arron Original Research Open access 01 March 2024 Pages: 593 - 612
Herpes Zoster Recurrence: A Narrative Review of the Literature Raunak ParikhO’Mareen SpenceIain Kaan Review Open access 28 February 2024 Pages: 569 - 592
Insights into Early Systemic Treatment in Atopic Dermatitis: Scientific Facts and Practical Considerations Efstratios VakirlisStamatios GregoriouEleni Sotiriou Commentary Open access 27 February 2024 Pages: 563 - 568
Readability of Patient Electronic Materials for Atopic Dermatitis in 23 Languages: Analysis and Implications for Dermatologists Tomasz SkrzypczakAnna SkrzypczakJacek C. Szepietowski Original Research Open access 24 February 2024 Pages: 671 - 684
Inhibition of Receptor-Interacting Protein Kinase 1 in Chronic Plaque Psoriasis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Valerie J. LudbrookDavid C. BuddWei Jing Loo Original Research Open access 19 February 2024 Pages: 489 - 504
Letter to the Editor Regarding ‘Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab Versus Dupilumab in Moderate-to-Severe Atopic Dermatitis’ Mike BastianNick FreemantlePatricia Guyot Letter Open access 16 February 2024 Pages: 819 - 821
Clinical and Disease Burden of Patients with Generalized Pustular Psoriasis: A Review of Real-World Evidence Tina BhutaniAaron S. Farberg Review Open access 16 February 2024 Pages: 341 - 360
Improvements in Plaque Psoriasis Associated with Calcipotriol/Betamethasone Aerosol Foam Treatment: A Post Hoc Analysis of Non-interventional Studies and Clinical Experience Sascha GerdesAnna CampanatiElizabeth Lazaridou Brief Report Open access 15 February 2024 Pages: 793 - 804